Investing in an early stage company is inherently risky.   When you make that investment, you place a lot of trust in the leadership team.  You hope they have the mettle weather the unforeseen hurdles, be able to fight through adversity, and find a way to succeed. 

At Nemucore, we are committed to working tirelessly to develop medicine to help in the fight against AML. But, at our core, the Nemucore team is committed to improving the lives of all cancer patients and our passion runs deeper than our day jobs as we are committed to helping cancer charities.  

This year, I ran the Boston Marathon to raise money to support the life saving care for Pediatric Hematology Oncology patients.  As you might have heard, the weather conditions were “less than ideal” however I managed to run a personal best.

It today’s world, it is often difficult to know the people you invest in personally.  However, we hope this example of our commitment to improving the lives of all cancer patients helps you become comfortable knowing that you chosen a team that has the resolve to see NMI-900 successfully cross the finish line to help patients afflicted with AML.